179 related articles for article (PubMed ID: 26852943)
1. Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.
Irwin JA; Erisir A; Kwon I
Curr Alzheimer Res; 2016; 13(6):663-77. PubMed ID: 26852943
[TBL] [Abstract][Full Text] [Related]
2. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
Chen X; Hu J; Jiang L; Xu S; Zheng B; Wang C; Zhang J; Wei X; Chang L; Wang Q
Neuroscience; 2014 Oct; 279():94-101. PubMed ID: 25193238
[TBL] [Abstract][Full Text] [Related]
3. A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-β neurotoxicity by generating nontoxic aggregates.
Wong HE; Qi W; Choi HM; Fernandez EJ; Kwon I
ACS Chem Neurosci; 2011 Nov; 2(11):645-57. PubMed ID: 22860159
[TBL] [Abstract][Full Text] [Related]
4. Oligomeric Amyloid-β Toxicity Can Be Inhibited by Blocking Its Cellular Binding in Cortical Neuronal Cultures with Addition of the Triphenylmethane Dye Brilliant Blue G.
Jana MK; Cappai R; Ciccotosto GD
ACS Chem Neurosci; 2016 Aug; 7(8):1141-7. PubMed ID: 27258855
[TBL] [Abstract][Full Text] [Related]
5. Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2.
Wilcock DM; Lewis MR; Van Nostrand WE; Davis J; Previti ML; Gharkholonarehe N; Vitek MP; Colton CA
J Neurosci; 2008 Feb; 28(7):1537-45. PubMed ID: 18272675
[TBL] [Abstract][Full Text] [Related]
6. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
[TBL] [Abstract][Full Text] [Related]
7. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier penetration of an Aβ-targeted, arginine-rich, d-enantiomeric peptide.
Jiang N; Frenzel D; Schartmann E; van Groen T; Kadish I; Shah NJ; Langen KJ; Willbold D; Willuweit A
Biochim Biophys Acta; 2016 Nov; 1858(11):2717-2724. PubMed ID: 27423267
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease.
Liu X; Hao W; Qin Y; Decker Y; Wang X; Burkart M; Schötz K; Menger MD; Fassbender K; Liu Y
Brain Behav Immun; 2015 May; 46():121-31. PubMed ID: 25637484
[TBL] [Abstract][Full Text] [Related]
11. Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model.
Qiao J; Wang J; Wang H; Zhang Y; Zhu S; Adilijiang A; Guo H; Zhang R; Guo W; Luo G; Qiu Y; Xu H; Kong J; Huang Q; Li XM
Glia; 2016 Feb; 64(2):240-54. PubMed ID: 26446044
[TBL] [Abstract][Full Text] [Related]
12. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
[TBL] [Abstract][Full Text] [Related]
13. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
14. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E
Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395
[TBL] [Abstract][Full Text] [Related]
15. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
Fragkouli A; Tsilibary EC; Tzinia AK
Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
[TBL] [Abstract][Full Text] [Related]
17. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
18. Antroquinonol Lowers Brain Amyloid-β Levels and Improves Spatial Learning and Memory in a Transgenic Mouse Model of Alzheimer's Disease.
Chang WH; Chen MC; Cheng IH
Sci Rep; 2015 Oct; 5():15067. PubMed ID: 26469245
[TBL] [Abstract][Full Text] [Related]
19. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
20. [Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs].
He M; Liu MY; Wang S; Tang QS; Yao WF; Zhao HS; Wei MJ
Zhong Yao Cai; 2012 Oct; 35(10):1641-4. PubMed ID: 23627134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
